Skip to search formSkip to main contentSkip to account menu

Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed

Known as: Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed, DTaP, Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine 
A vaccine containing detoxified tetanus toxoid, detoxified diphtheria toxoid and acellular pertussis antigens, adsorbed on aluminum phosphate, with… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Mercury (Hg) exposure in human infants and fetuses has long been known to be significantly associated with neurodevelopmental… 
2011
2011
  • M. Friedrich
  • 2011
  • Corpus ID: 5186181
BEFORE THE AVAILABILITY OF THE pertussis vaccine, more than 270 000 cases and 10 000 deaths were reported annually in the United… 
2010
2010
In February 2006, the Advisory Committee on Immunization Practices (ACIP) recommended routine vaccination of all U.S. infants… 
Review
2004
Review
2004
Vaccination rates are at or near alltime highs, while vaccine-preventable disease rates are at or near record lows. Reasons for… 
2003
2003
  • 2003
  • Corpus ID: 46068830
On December 13, 2002, the U.S. Food and Drug Administration (FDA) licensed a combined diphtheria and tetanus toxoids and… 
2003
2003
BACKGROUND The control and elimination of several deadly childhood diseases are a result of extensive vaccination efforts made by… 
Review
1999
Review
1999
NAVA's acellular pertussis vaccine is based on highly purified pertussis toxin (PT) inactivated with H(2)O(2). PT was analysed… 
1998
1998
Immunogenicity and vaccine potency of carrier proteins of two different PRP‐tetanus toxoid (PRP‐T) conjugated vaccines, produced…